Neuroactive steroids and peripheral neuropathy

Brain Research Reviews

Volumn 57, Issue 2, 2008, Pages 460-469

  Roglio, Ilaria ^a   Giatti, Silvia ^a   Pesaresi, Marzia ^a   Bianchi, Roberto ^b   Cavaletti, Guido ^c   Lauria, Giuseppe ^d   Garcia Segura, Luis Miguel ^e   Melcangi, Roberto Cosimo ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^c UNIVERSITY OF MILANO BICOCCA   (Italy)

^d DEPARTMENT OF NEUROSURGERY   (Italy)

^e INSTITUTO CAJAL   (Spain)

Author keywords

5 reductase; Progesterone; Schwann cells; Sciatic nerve; Testosterone; Tetrahydroprogesterone

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; 4 AMINOBUTYRIC ACID B RECEPTOR; AMPA RECEPTOR; KAINIC ACID RECEPTOR; MYELIN PROTEIN; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NEUROSTEROID; PROGESTERONE; SEROTONIN 3 RECEPTOR; STEROID 5ALPHA REDUCTASE; TESTOSTERONE; TETRAHYDROPROGESTERONE;

AGING; CELL PROLIFERATION; DIABETIC NEUROPATHY; HEREDITARY MOTOR SENSORY NEUROPATHY; NERVE REGENERATION; NEUROMODULATION; NEUROPROTECTION; NONHUMAN; PERIPHERAL NERVE INJURY; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REVIEW; SCHWANN CELL; SCIATIC NERVE; STEROID METABOLISM; STEROIDOGENESIS;

ANIMALS; HUMANS; PERIPHERAL NERVES; PERIPHERAL NERVOUS SYSTEM DISEASES; SCHWANN CELLS; STEROIDS;

EID: 40749124836     PISSN: 01650173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainresrev.2007.04.010     Document Type: Review

References (101)

1. Aguado-Llera D., Arilla-Ferreiro E., Chowen J.A., Argente J., Puebla-Jemenez L., Frago L.M., and Barrios V. 17beta-estradiol protects depletion of rat temporal cortex somatostatinergic system by beta-amyloid. Neurobiol. Aging (2006) (Electronic publication ahead of print)
2. Al-Dahan M.I., Jalilian Tehrani M.H., and Thalmann R.H. Regulation of gamma-aminobutyric acid B (GABA-B) receptors in the cerebral cortex during the estrous cycle. Brain Res. 640 (1994) 33-39
3. Al-Dahan M.I., and Thalmann R.H. Progesterone regulates gamma-aminobutyric acid B (GABA-B) receptors in the neocortex of female rats. Brain Res. 727 (1996) 40-48
4. Ayhan S., Markal N., Siemionow K., Araneo B., and Simionow M. Effect of subepineurial dehydroepiandrosterone treatment on healing of transected nerves repaired with the epineurial sleeve technique. Microsurgery 23 (2003) 49-55
5. Azcoitia I., Leonelli E., Magnaghi V., Veiga S., Garcia-Segura L.M., and Melcangi R.C. Progesterone and its derivatives dihydroprogesterone and tetrahydroprogesterone reduce myelin fiber morphological abnormalities and myelin fiber loss in the sciatic nerve of aged rats. Neurobiol. Aging 24 (2003) 853-860
6. Bartolami S., Auge C., Travo C., Venteo S., Knipper M., and Sans A. Vestibular Schwann cells are a distinct subpopulation of peripheral glia with specific sensitivity to growth factors and extracellular matrix components. J. Neurobiol. 57 (2003) 270-290
7. Benmessahel Y., Troadec J.-D., Cadepond F., Guennoun R., Buchanan Hales D., Schumacher M., and Groyer G. Downregulation of steroidogenic acute regulatory protein (StAR) gene expression by cyclic AMP in cultured Schwann cells. Glia 45 (2004) 213-228
8. Berry E.M. Dietary fatty acids in the management of diabetes mellitus. Am. J. Clin. Nutr. 66 (1997) 991S-997S
9. Bethea C.L., Lu N.Z., Gundlah C., and Streicher J.M. Diverse actions of ovarian steroids in the serotonin neural system. Front. Neuroendocrinol. 23 (2002) 41-100
10. Bianchi R., Buyukakilli B., Brines M., Savino C., Cavaletti G., Oggioni N., Lauria G., Borgna M., Lombardi R., Cimen B., Comelekoglu U., Kanik A., Tataroglu C., Cerami A., and Ghezzi P. Erythropoietin both protects from and reverses experimental diabetic neuropathy. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 823-828
11. Biessels G.-J., Cristino N.A., Rutten G.-J., Hamers F.P.T., Erkelens D.W., and Gispen W.H. Neurophysiological changes in the central and peripheral nervous system of streptozotocin-diabetic rats. Brain 122 (1999) 757-768
12. Cavarretta I.T.R., Martini L., Motta M., Smith C.L., and Melcangi R.C. SRC-1 coactivator is involved in the control of the gene expression of myelin protein P0. J. Mol. Neurosci. 24 (2004) 217-226
13. Chan J.R., Phillis II L.J., and Glaser M. Glucocorticoids and progestins signal the initiation and enhance the rate of myelin formation. Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 10459-10464
14. Chan J.R., Rodriguez-Waitkus P.M., Ng B.-K., Liang P., and Glaser M. Progesterone synthesized by Schwann cells during myelin formation regulates neuronal gene expression. Mol. Biol. Cell 11 (2000) 2283-2295
15. Chavez-Delgado M.E., Gomez-Pinedo U., Feria-Velasco A., Huerta-Viera M., Castaneda S.C., Toral F.A., Parducz A., Anda S.L., Mora-Galindo J., and Garcia-Estrada J. Ultrastructural analysis of guided nerve regeneration using progesterone- and pregnenolone-loaded chitosan prostheses. J. Biomed. Materi. Res. B Appl. Biomater. 74 (2005) 589-600
16. Ciriza I., Azcoitia I., and Garcia-Segura L.M. Reduced progesterone metabolites protect rat hippocampal neurons from kainic acid excitotoxicity in vivo. J. Neuroendocrinol. 16 (2004) 58-63
17. Coggeshall R.E., and Carlton S.M. Ultrastructural analysis of NMDA, AMPA, and kainate receptors on unmyelinated and myelinated axons in the periphery. J. Comp. Neurol. 391 (1998) 78-86
18. Coirini H., Gouézou M., Delespierre B., Liere P., Pianos A., Eychenne B., Schumacher M., and Guennoun R. Characterization and regulation of the 3β-hydroxysteroid dehydrogenase isomerase enzyme in the rat sciatic nerve. J. Neurochem. 84 (2003) 119-126
19. Dememes D., Lleixa A., and Dechesne C.J. Cellular and subcellular localization of AMPA-selective glutamate receptors in the mammalian peripheral vestibular system. Brain Res. 671 (1995) 83-94
20. Désarnaud F., Do Thi A.N., Brown A.M., Lemke G., Suter U., Baulieu E.E., and Schumacher M. Progesterone stimulates the activity of the promoters of peripheral myelin protein-22 and protein zero genes in Schwann cells. J. Neurochem. 71 (1998) 1765-1768
21. Désarnaud F., Bidichandani S., Patel P.I., Baulieu E.E., and Schumacher M. Glucocorticosteroids stimulate the activity of the promoters of peripheral myelin protein-22 and protein zero genes in Schwann cells. Brain Res. 865 (2000) 12-16
22. D'Urso D., Brophy P.J., Staugaitus S.M., Gillespie C.S., Frey A.B., Stempak J.G., and Colman D.R. Protein zero of peripheral nerve myelin: biosynthesis, membrane insertion, and evidence for homotypic interaction. Neuron 4 (1990) 449-460
23. D'Urso D., Eherhardt P., and Muller H.W. Peripheral myelin protein 22 and protein zero: a novel association in peripheral nervous system myelin. J. Neurosci. 19 (1999) 3396-3403
24. Eckersley L. Role of the Schwann cell in diabetic neuropathy. Int. Rev. Neurobiol. 50 (2002) 293-321
25. England J.D., and Asbury A.K. Peripheral neuropathy. Lancet 363 (2004) 2151-2161
26. Falkestein E., and Wehling M. Nongenomically initiated steroid actions. Eur. J. Clin. Investig. 30 (2000) 51-54
27. Ferzaz B., Brault E., Bourliaud G., Robert J.P., Poughon G., Claustre Y., Marguet F., Liere P., Schumacher M., Nowicki J.P., Fournier J., Marabout B., Sevrin M., George P., Soubrie P., Benavides J., and Scatton B. SSR180575 (7-chloro-N,N,5-trimethyl-4-oxo-3-phenyl-3,5-dihydro-4H-pyridazino[4,5-b]indole-1 acetamide), a peripheral benzodiazepine receptor ligand, promotes neuronal survival and repair. J. Pharmacol. Exp. Ther. 301 (2002) 1067-1078
28. Frye C.A., Van Keuren K.R., and Erkine M.S. Behavioral effects of 3alpha-androstanediol. I: modulation of sexual receptivity and promotion of GABA-stimulated chloride flux. Behav. Brain Res. 79 (1996) 109-118
29. Giese K.P., Martini R., Lemke G., Soriano P., and Schachner M. Mouse P0 gene disruption leads to hypomyelination, abnormal expression of recognition molecules, and degeneration of myelin and axons. Cell 71 (1992) 565-576
30. Greene D.A., Lattimer-Greene S., and Sima A.A. Pathogenesis of diabetic neuropathy: role of altered phosphoinositide metabolism. Crit. Rev. Neurobiol. 5 (1989) 143-219
31. Griffin L.D., Gong W., Verot L., and Mellon S.H. Niemann-pick type C disease involves disrupted neurosteroidogenesis and responds to allopregnanolone. Nat. Med. 10 (2004) 704-711
32. Groyer G., Eychenne B., Girard C., Rajkowski K., Schumacher M., and Cadepond F. Expression and functional state of the corticosteroid receptors and 11 beta-hydroxysteroid dehydrogenase type 2 in Schwann cells. Endocrinology 147 (2006) 4339-4350
33. Gu G., and Simerly R.B. Hormonal regulation of opioid peptide neurons in the anteroventral periventricular nucleus. Horm. Behav. 28 (1994) 503-511
34. Gudemez E., Ozer K., Cunningham B., Siemionow K., Browne E., and Siemionow M. Dehydroepiandrosterone as an enhancer of functional recovery following crush injury to rat sciatic nerve. Microsurgery 22 (2002) 234-241
35. Guennoun R., Schumacher M., Robert F., Delespierre B., Gouezou M., Eychenne B., Akwa Y., Robel P., and Baulieu E.E. Neurosteroids: expression of functional 3β-hydroxysteroid dehydrogenase by rat sensory neurons and Schwann cells. J. Neurosci. 9 (1997) 2236-2247
36. Guennoun R., Benmessahel Y., Delespierre B., Gouezou M., Rajkowski K.M., Baulieu E.E., and Schumacher M. Progesterone stimulates Krox-20 gene expression in Schwann cells. Mol. Brain Res. 90 (2001) 75-82
37. Heesch C.M., and Foley C.M. CNS effects of ovarian hormones and metabolites on neural control of circulation. Ann. N.Y. Acad. Sci. 940 (2001) 348-360
38. Horishita T., Minami K., Uezono Y., Shiraishi M., Ogata J., Okamoto T., Terada T., and Sata T. The effects of the neurosteroids: pregnenolone, progesterone and dehydroepiandrosterone on muscarinic receptor-induced responses in Xenopus oocytes expressing M1 and M3 receptors. Naunyn-Schmiedebergs Arch. Pharmakol. 371 (2005) 221-228
39. Huppenbauer C.B., Tanzer L., DonCarlos L.L., and Jones K.J. Gonadal steroid attenuation of developing hamster facial motoneuron loss by axotomy: equal efficacy of testosterone, dihydrotestosterone, and 17-beta estradiol. J. Neurosci. 25 (2005) 4004-4013
40. Ishaque A., Roomi M.W., Szymanska I., Kowalki S., and Eylar E.H. The P0 glycoprotein of peripheral nerve myelin. Can. J. Biochem. 58 (1980) 913-921
41. Islamov R.R., Hendrick W.A., Jones R.J., Lyall G.J., Spanier N.S., and Murashov A.K. 17beta-estradiol stimulates regeneration of sciatic nerve in female mice. Brain Res. 943 (2002) 283-286
42. Islamov R.R., Hendricks W.A., Katwa L.C., McMurray R.J., Pak E.S., Spanier N.S., and Murashov A.K. Effect of 17beta-estradiol on gene expression in lumbar spinal cord following sciatic nerve crush injury in ovariectomized mice. Brain Res. 966 (2003) 65-75
43. Jones K.J., Brown T.J., and Damaser M. Neuroprotective effects of gonadal steroids on regenerating peripheral motoneurons. Brain Res. Rev. 37 (2001) 372-382
44. Jordan Jr. C.L., Price R.H., and Handa R.J. Androgen receptor messenger RNA and protein in adult rat sciatic nerve: implications for site of androgen action. J. Neurosci. Res. 69 (2002) 509-518
45. Jung-Testas I., Schumacher M., Robel P., and Baulieu E.E. Demonstration of progesterone receptors in rat Schwann cells. J. Steroid Biochem. Mol. Biol. 58 (1996) 77-82
46. Koenig H.L., Schumacher M., Ferzaz B., Do Thi A.N., Ressouches A., Guennoun R., Jung-Testas I., Robel P., Akwa Y., and Baulieu E.E. Progesterone synthesis and myelin formation by Schwann cells. Science 268 (1995) 1500-1503
47. Lacor P., Benavides J., and Ferzaz B. Enhanced expression of the peripheral benzodiazepine receptor (PBR) and its endognous ligand octadecaneuropeptide (ODN) in the regenerating adult rat sciatic nerve. Neurosci. Lett. 220 (1996) 61-65
48. Lacor P., Gandolfo P., Tonon M.-C., Brault E., Dalibert I., Schumacher M., Benavides J., and Ferzaz B. Regulation of the expression of peripheral benzodiazepine receptors and their endogenous ligands during rat sciatic nerve degeneration and regeneration: a role for PBR in neurosteroidogenesis. Brain Res. 815 (1999) 70-80
49. Lambert J.J., Belelli D., Harney S.C., Peters J.A., and Frenguelli B.G. Modulation of native and recombinant GABA-A receptors by endogenous and synthetic neuroactive steroids. Brain Res. Rev. 37 (2001) 68-80
50. Lambert J.J., Belelli D., Peden D.R., Vardy A.W., and Peters J.A. Neurosteroid modulation of GABA-A receptors. Prog. Neurobiol. 71 (2003) 67-80
51. Lapchak P.A., and Araujo D.M. Preclinic development of neurosteroids as neuroprotective agents for the treatment of neurodegenerative disease. Int. Rev. Neurobiol. 46 (2001) 379-397
52. Lauria G., Morbin M., Lombardi R., Borgna M., Mazzoleni G., Sghirlanzoni A., and Pareyson D. Axonal swellings predict the degeneration of epidermal nerve fibers in painful neuropathies. Neurology 61 (2003) 631-636
53. Lauria G., Lombardi R., Borgna M., Penza P., Bianchi R., Savino C., Canta A., Nicolini G., Marmiroli P., and Cavaletti G. Intraepidermal nerve fiber density in rat foodpad: neuropathologic-neurophysiologic correlation. J. Peripher. Nerv. Syst. 10 (2005) 199-205
54. Leonelli E., Yague J.G., Ballabio M., Azcoitia I., Magnaghi V., Schumacher M., Garcia-Segura L.M., and Melcangi R.C. Ro5-4864, a synthetic ligand of peripheral benzodiazepine receptor, reduces aging-associated myelin degeneration in the sciatic nerve of male rats. Mech. Ageing Dev. 126 (2005) 1159-1163
55. Leonelli E., Bianchi R., Cavaletti G., Caruso D., Crippa D., Garcia-Segura L.M., Lauria G., Magnaghi V., Roglio I., and Melcangi R.C. Progesterone and its derivatives are neuroprotective agents in experimental diabetic neuropathy: a multimodal analysis. Neuroscience 144 (2007) 1293-1304
56. Lubischer J.L., and Bebinger D.M. Regulation of terminal Schwann cell number at the adult neuromuscular junction. J. Neurosci. 19 (1999) RC46
57. Magnaghi V., Cavarretta I., Zucchi I., Susani L., Rupprecht R., Hermann B., Martini L., and Melcangi R.C. P0 gene expression is modulated by androgens in the sciatic nerve of adult male rats. Mol. Brain Res. 70 (1999) 36-44
58. Magnaghi V., Cavarretta I., Galbiati M., Martini L., and Melcangi R.C. Neuroactive steroids and peripheral myelin proteins. Brain Res. Rev. 37 (2001) 360-371
59. Magnaghi V., Ballabio M., Cavarretta I.T.R., Froestl W., Lambert J.J., Zucchi I., and Melcangi R.C. GABA-B receptors in Schwann cells influence proliferation and myelin protein expression. Eur. J. Neurosci. 19 (2004) 2641-2649
60. Magnaghi V., Ballabio M., Gonzalez L.C., Leonelli E., Motta M., and Melcangi R.C. The synthesis of glycoprotein P0 and peripheral myelin protein 22 in sciatic nerve of male rats is modulated by testosterone metabolites. Mol. Brain Res. 126 (2004) 67-73
61. Magnaghi V., Veiga S., Ballabio M., Gonzales L.C., Garcia-Segura L.M., and Melcangi R.C. Sex-dimorphic effects of progesterone and its reduced metabolites on gene expression of myelin proteins by rat Schwann cells. J. Peripher. Nerv. Syst. 11 (2006) 111-118
62. Magnaghi V., Ballabio M., Roglio I., and Melcangi R.C. Progesterone derivatives increase the expression of Krox-20 and Sox-10 in rat Schwann cells. J. Mol. Neurosci. 31 (2007) 149-157
63. Martini R., Zielasek J., Toyka K.V., Giese K.P., and Schachner M. Protein zero (P0)-deficient mice show myelin degeneration in peripheral nerves characteristic of inherited human neuropathies. Nat. Genet. 11 (1995) 281-286
64. Maurice T., Urani A., Phan V.L., and Romieu P. The interaction between neuroactive steroids and the sigma 1 receptor function: behavioral consequences and therapeutic opportunities. Brain Res. Rev. 37 (2001) 116-132
65. McCullogh L.D., and Hurn P.D. Estrogen and ischemic neuroprotection: an integrated view. Trends Endocrinol. Metab. 14 (2003) 228-235
66. Melcangi R.C., Magnaghi V., Cavarretta I., Martini L., and Piva F. Age-induced decrease of glycoprotein P0 and myelin basic protein gene expression in the rat sciatic nerve. Repair by steroid derivatives. Neuroscience 85 (1998) 569-578
67. Melcangi R.C., Magnaghi V., Cavarretta I., Zucchi I., Bovolin P., D'Urso D., and Martini L. Progesterone derivatives are able to influence peripheral myelin protein 22 and P0 gene expression: possible mechanisms of action. J. Neurosci. Res. 56 (1999) 349-357
68. Melcangi R.C., Magnaghi V., Galbiati M., Ghelarducci B., Sebastiani L., and Martini L. The action of steroid hormones on peripheral myelin proteins: a possible new tool for the rebuilding of myelin?. J. Neurocytol. 29 (2000) 327-339
69. Melcangi R.C., Magnaghi V., and Martini L. Aging in peripheral nerves: regulation of myelin protein genes by steroid hormones. Prog. Neurobiol. 60 (2000) 291-308
70. Melcangi R.C., Magnaghi V., Galbiati M., and Martini L. Glial cells: a target for steroid hormones. Prog. Brain Res. 132 (2001) 31-40
71. Melcangi R.C., Magnaghi V., Galbiati M., and Martini L. Formation and effects of neuroactive steroids in the central and peripheral nervous system. Int. Rev. Neurobiol. 46 (2001) 145-176
72. Melcangi R.C., Leonelli E., Magnaghi V., Gherardi G., Nobbio L., and Schenone A. Mifepristone (RU 38486) influences expression of glycoprotein P0 and morphological parameters at the level of rat sciatic nerve: in vivo observations. Exp. Neurol. 184 (2003) 930-938
73. Melcangi R.C., Azcoitia I., Ballabio M., Cavarretta I., Gonzalez L.C., Leonelli E., Magnaghi V., Veiga S., and Garcia-Segura L.M. Neuroactive steroids influence peripheral myelination: a promising opportunity for preventing or treating age-dependent disfunctions of peripheral nerves. Prog. Neurobiol. 71 (2003) 57-66
74. Melcangi R.C., Cavarretta I.T., Ballabio M., Leonelli E., Schenone A., Azcoitia I., Garcia-Segura L.M., and Magnaghi V. Peripheral nerves: a target for the action of neuroactive steroids. Brain Res. Rev. 48 (2005) 328-338
75. Mercier G., Turque N., and Schumacher M. Early activation of transcription factor expression in Schwann cells by progesterone. Mol. Brain Res. 97 (2001) 137-148
76. Naef R., and Suter U. Many facets of the peripheral myelin protein PMP22 in myelination and disease. Microsc. Res. Tech. 41 (1998) 359-371
77. Notelovitz M. Hot flashes and androgens: a biological rationale for clinical practice. Mayo Clin. Proc. 79 (2004) S8-S13
78. Palacios G., Muro A., Verdu E., Pumarola M., and Vela J.M. Immunohistochemical localization of the sigma (1) receptor in Schwann cells of rat sciatic nerve. Brain Res. 1007 (2004) 65-70
79. Papadopoulos V., Baraldi M., Guilarte T.R., Knudsen T.B., Lacapere J.J., Lindemann P., Norenberg M.D., Nutt D., Weizman A., Zhang M.R., and Gavish M. Translocator protein (18 kDa): new nomenclature for the peripheral-type benzodiazepine receptor based on its structure and molecular function. Trends Pharmacol. Sci. 27 (2006) 402-409
80. Pareek S., Suter U., Snipes G.J., Welcher A.A., Shooter E.M., and Murphy R.A. Detection and processing of peripheral myelin protein PMP22 in cultured Schwann cells. J. Biol. Chem. 268 (1993) 10372-10379
81. Periquet M.I., Novak V., Collins M.P., Nagaraja H.N., Erdem S., Nash S.M., Freimer M.L., Sahenk Z., Kissel J.T., and Mendell J.R. Painful sensory neuropathy: prospective evaluation using skin biopsy. Neurology 53 (1999) 1641-1647
82. Rodriguez-Waitkus P.M., LaFollette A.J., Ng B.K., Zhu T.S., Conrad H.E., and Glaser M. Steroid hormone signaling between Schwann cells and neurons regulates the rate of myelin synthesis. Ann. N.Y. Acad. Sci. 1007 (2003) 340-348
83. Romieu P., Martin-Fardon R., Bowen W.D., and Maurice T. Sigma 1 receptor-related neuroactive steroids modulate cocaine-induced reward. J. Neurosci. 23 (2003) 3372-3376
84. Rupprecht R., di Michele F., Hermann B., Strohle A., Lancel M., Romeo E., and Holsboer F. Neuroactive steroids: molecular mechanisms of action and implications for neuropsychopharmacology. Brain Res. Rev. 37 (2001) 59-67
85. Schumacher M., Guennoun R., Mercier G., Désarnaud F., Lacor P., Bénavides J., Ferzaz B., Robert F., and Baulieu E.E. Progesterone synthesis and myelin formation in peripheral nerves. Brain Res. Rev. 37 (2001) 343-359
86. Schumacher M., Weill-Engerer S., Liere P., Robert F., Franklin R.J.M., Garcia-Segura L.M., Lambert J.J., Mayo W., Melcangi R.C., Parducz A., Suter U., Carelli C., Baulieu E.E., and Akwa Y. Steroid hormones and neurosteroids in normal and pathological aging of the nervous system. Prog. Neurobiol. 71 (2003) 3-29
87. Sugimoto K., Murakawa Y., and Sima A.A.F. Diabetic neuropathy-a continuing enigma. Diabetes Metab. Res. Rev. 16 (2000) 408-433
88. Suter U., and Scherer S.S. Disease mechanisms in inherited neurophathies. Nat. Rev., Neurosci. 4 (2003) 714-726
89. Svenningsen A.F., and Kanje M. Estrogen and progesterone stimulate Schwann cell proliferation in a sex- and age-dependent manner. J. Neurosci. Res. 57 (1999) 124-130
90. Tanzer L., and Jones K.J. Gonadal steroid regulation of hamster facial nerve regeneration: effects of dihydrotestosterone and estradiol. Exp. Neurol. 146 (1997) 258-264
91. Tanzer L., and Jones K.J. Neurotherapeutic action of testosterone on hamster facial nerve regeneration: temporal window of effects. Horm. Behav. 45 (2004) 339-344
92. Traish A.M., and Guay A.T. Are androgens critical for penile erections in humans? Examining the clinical and preclinical evidence. J. Sex. Reprod. Med. 3 (2006) 382-404
93. Veiga S., Leonelli E., Beelke M., Garcia-Segura L.M., and Melcangi R.C. Neuroactive steroids prevent peripheral myelin alterations induced by diabetes. Neurosci. Lett. 402 (2006) 150-153
94. Verkhratsky A., and Steinhauser C. Ion channels in glial cells. Brain Res. Rev. 32 (2000) 380-412
95. Vinik A.I., Park T.S., Stansberry K.B., and Pittenger G.L. Diabetic neuropathies. Diabetologia 43 (2000) 957-973
96. Vita G., Dattola R., Girlanda P., Oteri G., Lo Presti F., and Messina C. Effects of steroid hormones on muscle reinnervation after nerve crush in rabbit. Exp. Neurol. 80 (1983) 279-287
97. Yagihashi S. Nerve structural defects in diabetic neuropathy: do animals exhibit similar changes?. Neurosci. Res. Commun. 21 (1997) 25-32
98. Yokoi H., Tsuruo Y., and Ishimura K. Steroid 5α-reductase type 1 immunolocalized in the rat peripheral nervous system and paraganglia. Histochem. J. 30 (1998) 731-739
99. Yorek M.A., Coppey L.J., Gellett J.S., Davidson E.P., Bing X., Lund D.D., and Dillon J.S. Effect of treatment of diabetic rats with dehydroepiandrosterone on vascular and neural function. Am. J. Physiol: Endocrinol. Metab. 283 (2002) E1067-E1075
100. Yu W.H. Effect of testosterone on the regeneration of the hypoglossal nerve in rats. Exp. Neurol. 77 (1982) 129-141
101. Zielasek J., Martini R., and Toyka K.V. Functional abnormalities in P0-deficient mice resemble human hereditary neuropathies linked to P0 gene mutations. Muscle Nerve 19 (1996) 946-952